Erythromycin USP 250mg
Erythromycin has been used in the treatment of a wide variety of infections caused by susceptible organism. Its uses include bronchitis, severe campylobacter enteritis, chancroid, diphtheria, and legionella infection. It is used as an alternative to penicillin in penicillin-allergic patients with various conditions like anthrax, actinomycosis, leptospirosis, pelvic inflammatory disease, pharyngitis, the prevention of perinatal streptococcal infection and rheumatic fever. It is used as an alternative to tetracycline in patients with Chlamydia infections.
Erythromycin USP 250mg
Erythromycin has been used in the treatment of a wide variety of infections caused by susceptible organism. Its uses include bronchitis, severe campylobacter enteritis, chancroid, diphtheria, and legionella infection. It is used as an alternative to penicillin in penicillin-allergic patients with various conditions like anthrax, actinomycosis, leptospirosis, pelvic inflammatory disease, pharyngitis, the prevention of perinatal streptococcal infection and rheumatic fever. It is used as an alternative to tetracycline in patients with Chlamydia infections.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.